[Experimental data to substantiate the antitumor action of hydrazine sulfate]
- PMID: 462860
[Experimental data to substantiate the antitumor action of hydrazine sulfate]
Abstract
It was found that under the influence of hydrazine sulfate, which in the dosage of 60 mg/kg would induce a 50% suppression of Walker carcinosarcoma in rats, there is the decreased activity of mitochondrial monoamine oxidase and a sharp reduction in the activity of some microsomal phosphatases. Vitamin B6 injection some hours before injecting hydrazine sulfate lessens the rate of suppression of the tumor growth up to 50%. The results obtained indicate that the antitumor effect of hydrazine sulfate may be related to the suppressed monoamine oxidate activity and vitamin B6 deficiency.
Similar articles
-
[Selective action of hydrazine sulfate in combination with thiophosphamide on tumor cell mitochondria].Vopr Onkol. 1982;28(3):86-8. Vopr Onkol. 1982. PMID: 6461132 Russian.
-
[Experimental and clinical data on the antitumor action of hydrazine sulfate].Vopr Onkol. 1975;21(1):45-52. Vopr Onkol. 1975. PMID: 1090085 Clinical Trial. Russian. No abstract available.
-
Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.Cancer Biochem Biophys. 1978;3(1):41-5. Cancer Biochem Biophys. 1978. PMID: 552898
-
[Experimental data on the toxic action of hydrazine sulfate on the body and on a tumor].Farmakol Toksikol. 1978 Mar-Apr;41(2):203-5. Farmakol Toksikol. 1978. PMID: 658367 Russian.
-
Metabolism of hydrazine anti-cancer agents.Pharmacol Ther. 1987;34(1):111-27. doi: 10.1016/0163-7258(87)90095-7. Pharmacol Ther. 1987. PMID: 3310042 Review. No abstract available.
Cited by
-
Experience of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer patients.Invest New Drugs. 1995;13(1):89-97. doi: 10.1007/BF02614227. Invest New Drugs. 1995. PMID: 7499115 Clinical Trial.